
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+1
Emalex Biosciences was created to develop new treatments for CNS disorders. It is in late-stage development of a new class of drug for patients with Tourette syndrome and other conditions that have limited treatment options
Pharmaceutical,biopharmaceutical,innovation,research and development,central nervous system (cns) disorders,and tourette syndrome
Emalex biosciences operates in the Biotechnology research industry.
Emalex biosciences's revenue is 11m - 100m
Emalex biosciences has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.